• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CROMSOURCE appoints Dr. Grzegorz Rychlik chief medical officer

CROMSOURCE appoints Dr. Grzegorz Rychlik chief medical officer

September 8, 2016
CenterWatch Staff

CROMSOURCE, an international CRO providing a comprehensive portfolio of services to the pharmaceutical, biotechnology, and medical device industries, announced the appointment of its new Chief Medical Officer Dr. Grzegorz Rychlik, and the expansion of its Medical Affairs Services department.

Dr. Rychlik has more than 26 years of experience in the pharmaceutical industry. He has held positions of increasing responsibility with sponsor and service companies of various sizes, including large, global organizations such as Pfizer, Novartis and Parexel, as well as virtual, small and mid-sized enterprises. Dr. Rychlik's most recent position was managing director with MRCD Pharma Services in the United Kingdom, and prior to that he served as medical director and chief medical officer for various organizations. His therapeutic expertise is closely aligned with CROMSOURCE's key areas of focus and expertise, namely oncology, ophthalmology, respiratory, cardiovascular, CNS and medical devices.

"The addition of an experienced and respected medical professional such as Greg strongly positions CROMSOURCEto be able to further support the increasingly complex product development needs of our clients. Additionally, as we expand our Medical Affairs offering we will optimize and grow our consultancy and medical services to better serveour clients," stated Dr. Oriana Zerbini, founder and chief executive officer of CROMSOURCE.

Dr. Troy McCall, CROMSOURCE chief operating officer, added, "We are very pleased to have Dr. Rychlik join the CROMSOURCE team. Under his leadership, CROMSOURCE will expand our medical monitoring, pharmacovigilance, and medical writing services to meet growing client needs. Having highly experienced and skilled individuals such as Greg within the Medical Affairs Services group will allow for the optimization and standardization of interdependent processes, while leveraging efficiencies and ensuring that the highest level of quality is delivered."

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing